Oscar Health

Oscar Health’s stock rose to a 52-week high of $34.09 and is currently trading at $33.81. Over the past year the stock gained 68.55%; in the last six months it rose 143% and year-to-date it is up 127%. In the second quarter Oscar Health beat expectations with adjusted earnings of $1.10 per share (expectation $0.37) and revenue of $4.88 billion (expectation $4.73 billion). Analysts currently view the stock as overvalued, according to InvestingPro, and there was a premarket price decline despite the strong quarterly results. » Mere på de.investing.com

Oscar Health’s stock climbed to a 52-week high of $33.12 and has a market capitalization of $10.17 billion and a P/E ratio of 17.27. Year-to-date the share price is up 110.1%, up 114% since the start of the year, and up 129% over six months. In the second quarter Oscar Health beat expectations with adjusted earnings per share of $1.10 and revenue of $4.88 billion; the company attributes the results to record profitability, improved medical cost trends and tighter cost control. An analysis by InvestingPro currently rates the stock as overvalued. » Mere på de.investing.com

Oscar Health reported $1 billion net income in the first half of 2026, citing disciplined pricing, operating leverage and AI tools (Oswell) that guided members to lower-cost care and identified pharmacy savings. Management raised full-year 2026 earnings from operations guidance to $500 million–$700 million and expects full-year MLR of 81.5%–82.5%, while forecasting higher churn in H2 as CMS eligibility verifications accelerate. Company noted a $160 million favorable 2025 risk-adjustment true-up, continued SG&A efficiency from its single-platform tech stack, and ongoing CMS reviews with anticipated impacts already reflected in guidance. » Mere på finance.yahoo.com

Oscar Health reported a $361.8 million second-quarter profit and $1.04 billion in net income for the first half of 2026, driven by revenue growth to $4.9 billion and an increase in health plan members to 2.9 million. The company credited disciplined pricing, scalable technology and $164 million of favorable prior-period reserve development for a lower medical loss ratio of 79.2%, down from 91.1% year over year. CEO Mark Bertolini said Oscar is positioned for continued profitable growth in the Affordable Care Act individual market and raised its full-year outlook on several metrics. » Mere på forbes.com

According to a report, Oscar Health has 3.2 million members and saw rising membership in the first quarter. The company is focusing on digital healthcare via an app and an AI assistant, which has generated increased investor interest. Oscar currently covers about 20 states and is viewed as a growth company; its stock was up roughly 36% over the reporting period. » Mere på finanzen.net